Breaking News

AMRI Wins Five-Year NIH Contract

To provide drug substance development and manufacturing services

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

AMRI was awarded a five-year federal contract from the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), for drug substance development and manufacturing services. The NCATS award will support the Division of Pre-Clinical Innovation’s (DPI) drug development programs by providing drug substance development and manufacturing services related to the synthesis and analysis of small molecules.  The goal of the DPI is to advance collabora...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters